Corporate Innovation/News/ Corporate innovation weekly: speedy unicorns and monitoring methane This is what Europe's largest companies have been investing in: used car marketplaces, methane monitoring, tech to speed up hiring and renting. By Maija Palmer 30 June 2020 \Corporate Innovation Purrsonalised health: The startups and VCs betting on pet genetics By Adam Green 15 September 2022 Corporate Innovation/News/ Corporate innovation weekly: speedy unicorns and monitoring methane This is what Europe's largest companies have been investing in: used car marketplaces, methane monitoring, tech to speed up hiring and renting. By Maija Palmer 30 June 2020 Automotive UK’s fastest unicorn Cazoo, the UK used car marketplace, reached a valuation of more than $1bn just 18 months after being founded, a record-breaking sprint to unicorn status. DMG Ventures, the investment arm of the Daily Mail and General Trust, was among the backers. Assisted driving Robert Bosch Venture Fund was one of the investors backing the $20m series C extension round for AImotive, the Hungarian automated driving software startup. As the dream of fully self-driving cars recedes a bit and shifts to assisted driving systems, software providers like AImotive could be in a good position. Energy Monitoring methane Satelytics, a startup that uses spectral imagery to monitor environmental changes, such as methane emissions, received a $5m investment from bp ventures. Financial services Equity capital markets A host of big banks, including Barclays, Citi, Fidelity Investments, Goldman Sachs, JP Morgan, and Morgan Stanley took part in the $25m investment in Capital Markets Gateway, a US fintech focused on equity capital markets. Healthcare Gut instinct Nestlé Health Sciences and Takeda Pharmaceutical were among the investors in the €46.3m Series E funding round for Enterome. The French biotech company is developing new drugs based on an understanding of the interaction between gut health and the body’s immune system. Second time lucky? Novartis-backed biotech Poseida is taking advantage of the stock market appetite for healthtech listings and is taking a second stab at launching the IPO it had to shelve last April. While waiting to list it has raised a $110m Series D funding round. The San Diego-based company is developing car-T therapies, where a patient’s own immune cells are reprogrammed to attack cancer. Big noise Akouos, the biotech developing gene therapies for hearing loss, raised $213m in its Nasdaq debut, nearly 70% more than expected. Novartis is one of the backers. Premature birth Banco Santander invested €600,000 in Innitius, a Spanish company developing technology to detect false signals of premature birth. Hospitality Down round Bertelsmann was one of the investors in Treebo Hotels, the Indian budget hotel chain, which has raised a Series D round that appears to have resulted in a €11.7m drop on valuation. Industrial Factory data Element Analytics, a San Francisco-based company that makes a platform to help organise the data generated by industrial companies, raised an $18m series B round, from investors including ABB Technology Ventures and Schneider Electric. Real estate Rental tech Foxton’s and Countrywide are the backers of a new proptech company, Propoly, which helps reduce some of the admin around setting up a new tenancy. Recruitment Smart hires Tempo, a UK hiring startup, secured £5m in a series A funding round led by recruitment company Adecco. Tempo claims to save businesses 65% of hiring costs by using machine learning to match job seekers to potential employers. Who’s hiring? Director, product marketing, Workplace, London, United Kingdom Digital strategy manager, AstraZeneca, Milan, Italy Innovation adviser, Newable, London, UK Digital innovation analyst, AXA, Weybridge, UK Principal – permitting innovation and integration, Anglo American, London, UK Data Scientist, L’Oréal, Saint-Ouen, France Good reads CVC overtakes VC (except in Europe) A truly amazing analysis by Eze Vidra, former general partner at Google Ventures, on why corporate venturing should no longer be dismissed as “tourist capital” that comes and goes. In the US in 2018 it accounted for 52% of all VC investments, overtaking non-corporate VC money for the first time. Europe has been slower to grow CVC – it accounted for just 38.7% of all VC funding in 2018. And of course we will have to see what happens now following the Covid crisis — but this is certainly a category of money that needs to be taken very seriously. It is not an innovation problem, it is a scaleup problem This is a very astute analysis of the corporate innovation problem by Ralph-Christian Ohr at Dual Innovation. Barely 10% of companies manage to grow revenue from a digital initiative to more than 5% of group revenue. How can companies improve? Ohr suggests companies need to be more honest about the kind of innovation project they need. Is it just a lab focused on ideation, a competency centre that makes prototypes, a solution provider or a full-fledged company builder? The latter two will need much bigger resources. Related Articles The world’s 50 most innovative companies — and what we can learn from them By Maija Palmer Click here to read more 64% of companies are cutting innovation budgets By Maija Palmer Click here to read more Hoping for a pet tech unicorn By Maija Palmer Click here to read more Most Read 1 \Healthtech Is Daniel Ek’s new body scanner worth the hype? Sifted tried it out 2 \Venture Capital VC diversity needs to change — and white men need to take responsibility 3 \Venture Capital New €3.75bn European Investment Fund pot to back late-stage VCs 4 \Sustainability Counteract closes £15m fund for carbon removal solutions 5 \Mobility Was the $5bn that VCs plugged into escooters worth it?